Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
260 studies found for:    "Diabetic Nephropathies"
Show Display Options
Rank Status Study
21 Completed
Has Results
Renoprotection in Early Diabetic Nephropathy in Pima Indians
Condition: Diabetic Nephropathy
Interventions: Drug: Losartan;   Drug: Placebo
22 Active, not recruiting Minocycline and Proteinuria in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Minocycline 100 mg po bid for 6 months;   Drug: placebo
23 Completed Delaying the Progression of Diabetic Nephropathy in Pima Indians
Condition: Diabetic Nephropathy
Intervention:
24 Recruiting Study Of Diabetic Nephropathy With Atrasentan
Condition: Diabetic Nephropathy
Interventions: Drug: Atrasentan;   Drug: Placebo
25 Completed Nitric Oxide (NO) Activity and Diabetic Nephropathy
Condition: Diabetic Nephropathies
Intervention: Drug: Folic Acid
26 Completed Adiponectin and Insulin Resistance in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Losartan
27 Unknown  An Investigation on the Effect of Candesartan on Early Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention:
28 Completed Study of LY3016859 in Participants With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Placebo;   Drug: LY3016859
29 Not yet recruiting Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathies
Interventions: Drug: Exenatide;   Drug: Lispro
30 Unknown  Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Beraprost sodium
31 Not yet recruiting Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy?
Condition: Diabetic Nephropathy
Interventions: Drug: telmisartan during 6 months;   Drug: Losartan during 6 months;   Procedure: blood sample
32 Completed The Effects of Bindarit in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Bindarit;   Drug: Placebo
33 Completed To Assess the Accuracy of the eZscan Study in the Screening for Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention:
34 Completed Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: RTA 402 (Bardoxolone Methyl)
35 Recruiting Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy
Condition: Diabetic Nephropathies
Interventions: Drug: Semi-individualised Chinese Medicine treatment;   Drug: Routine medical care (active comparator)
36 Completed To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: DW1029M 600mg;   Drug: DW1029M 1200mg;   Drug: Placebo
37 Completed A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Probucol;   Drug: Probucol and Cilostazol
38 Completed Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: spironolactone
39 Withdrawn Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria
Condition: Diabetic Nephropathy
Interventions: Drug: MLN1202 Placebo;   Drug: MLN1202
40 Completed INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy
Condition: Diabetic Nephropathies
Interventions: Drug: Telmisartan capsule 40 mg;   Drug: Placebo;   Drug: Telmisartan capsule 80 mg

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.